05: Using Machine Learning to test drug responses with Will Bowers

Will Bowers is a PhD researcher at the institute of Cancer Research. He is focusing on defining biomarkers of tyrosine kinase inhibitor response in soft tissue sarcoma. To break that down, soft tissue sarcoma (STS) is a rare cancer category (<1% of all cancers) which skews more towards young people. Receptor tyrosine kinase inhibitors (RTKIs) are a common drug used in chemotherapy, though some cancer types become resistant. By analysing blood samples and tumor biopsies, we can computationally assess how different patients respond to the drugs, then we can then predict which patients will have the best response in the future.

For Inquisitive Minds is a fortnightly podcast showcasing post graduate work in all areas. The podcast seeks to identify ground breaking research and bring it to the masses. Visit patreon.com/forinquisitiveminds to learn more about our work!